Nous ne pouvons afficher que des informations limitées pour ce cabinet. Nous affichons des informations plus complètes pour les cabinets suivants :
In April 2024, Toronto-based dispute resolution boutique Tyr LLP formed a new IP litigation practice through a series of strategic hires. Most notably, new department head Melanie Baird joined from Blake, Cassels & Graydon LLP along with senior associate Cole Meagher, who was later promoted to partner. Additionally, Amy Grenon arrived from Aird & Berlis LLP. The team has hit the ground running, demonstrating particularly strong activity in the life sciences space.
L’éditorial du Legal 500
Témoignages
Collectés indépendamment par l'équipe de recherche du Legal 500.
‘The members of the Tyr IP practice are smart, experienced and very good advocates. The group has excellent litigators, with their two most experienced IP litigators being women.’
‘Melanie Baird is an intelligent and effective patent litigator, with significant experience in pharmaceutical patent litigation. Amy Grenon is very experienced in all types of IP litigation, in particular pharmaceutical patent litigation. Both are at the top of their game.’
Clients clés
- Janssen
- Actelion Pharmaceuticals
Points forts
- Represented Janssen and Actelion Pharmaceuticals in respect of multiple actions against generic challengers concerning patents covering Janssen’s OPSUMIT product.
- Represented Janssen, Pharmacyclics and AbbVie in actions commenced against multiple generic challengers in respect of patents covering Janssen’s IMBRUVICA product.